Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Virus-specific TRM cells of both donor and recipient origin reside in human kidney transplants
Daphne M. Hullegie-Peelen, Hector Tejeda Mora, Dennis A. Hesselink, Eric M.J. Bindels, Thierry P.P. van den Bosch, Marian C. Clahsen-van Groningen, Marjolein Dieterich, Sebastiaan Heidt, Robert C. Minnee, Georges M.G.M. Verjans, Martin J. Hoogduijn, Carla C. Baan
Daphne M. Hullegie-Peelen, Hector Tejeda Mora, Dennis A. Hesselink, Eric M.J. Bindels, Thierry P.P. van den Bosch, Marian C. Clahsen-van Groningen, Marjolein Dieterich, Sebastiaan Heidt, Robert C. Minnee, Georges M.G.M. Verjans, Martin J. Hoogduijn, Carla C. Baan
View: Text | PDF
Research Article Immunology Transplantation

Virus-specific TRM cells of both donor and recipient origin reside in human kidney transplants

  • Text
  • PDF
Abstract

Tissue-resident lymphocytes (TRLs) are critical for local protection against viral pathogens in peripheral tissue. However, it is unclear if TRLs perform a similar role in transplanted organs under chronic immunosuppressed conditions. In this study, we aimed to characterize the TRL compartment in human kidney transplant nephrectomies and examine its potential role in antiviral immunity. The TRL compartment of kidney transplants contained diverse innate, innate-like, and adaptive TRL populations expressing the canonical residency markers CD69, CD103, and CD49a. Chimerism of donor and recipient cells was present in 43% of kidney transplants and occurred in all TRL subpopulations. Paired single-cell transcriptome and T cell receptor (TCR) sequencing showed that donor and recipient tissue–resident memory T (TRM) cells exhibit striking similarities in their transcriptomic profiles and share numerous TCR clonotypes predicted to target viral pathogens. Virus dextramer staining further confirmed that CD8 TRM cells of both donor and recipient origin express TCRs with specificities against common viruses, including CMV, EBV, BK polyomavirus, and influenza A. Overall, the study results demonstrate that a diverse population of TRLs resides in kidney transplants and offer compelling evidence that TRM cells of both donor and recipient origin reside within this TRL population and may contribute to local protection against viral pathogens.

Authors

Daphne M. Hullegie-Peelen, Hector Tejeda Mora, Dennis A. Hesselink, Eric M.J. Bindels, Thierry P.P. van den Bosch, Marian C. Clahsen-van Groningen, Marjolein Dieterich, Sebastiaan Heidt, Robert C. Minnee, Georges M.G.M. Verjans, Martin J. Hoogduijn, Carla C. Baan

×

Figure 6

Virus specificity of donor and recipient CD8 TRM cells.

Options: View larger image (or click on image) Download as PowerPoint
Virus specificity of donor and recipient CD8 TRM cells.
(A) Virus dextra...
(A) Virus dextramer staining and flow cytometric analysis to examine the virus specificity of CD8+ TRM cells using EBV, BKV, CMV, and influenza A dextramers in HLA-A2+ kidney transplant nephrectomies (n = 8). (B) Positive dextramer staining of recipient and donor TRM cells against EBV, BKV, CMV, and influenza A (INFL). Bars represent the median. A star indicates patients who were treated with alemtuzumab prior to explantation. (C) Total proportion of virus-specific cells among donor and recipient TRM cells in each sample. The time between transplantation and explantation is annotated on the x axis. A star indicates patients who have been treated with alemtuzumab prior to explantation. (D) Flow cytometry plots showing dextramer staining of donor and recipient TRM cells among the chimeric samples (study sample identifiers G9, G10, and G24). (E) Graphs showing the proportion of EBV-, BKV-, CMV-, and influenza A–specific donor (DON) and recipient (REC) TRM cells among the chimeric samples (G9, G10, and G24).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts